Response to The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19
- PMID: 32838110
- PMCID: PMC7361545
- DOI: 10.1002/rth2.12417
Response to The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19
References
-
- Warkentin TE, Nazy I, Sheppard JI, Smith JW, Kelton JG, Arnold DM. Serotonin‐release assay‐negative heparin‐induced thrombocytopenia. Am J Hematol. 2020;95:38–47. - PubMed
-
- Vayne C, Guery EA, Kizlik‐Masson C, Rollin J, Bauters A, Gruel Y, et al. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin‐induced thrombocytopenia antibodies. Br J Haematol. 2017;179:811–9. - PubMed
-
- Pandya KA, Johnson EG, Davis GA, Padmanabhan A. Serotonin release assay (SRA)‐negative HIT, a newly recognized entity: implications for diagnosis and management (Letter). Thromb Res. 2018;172:169–71. - PubMed
LinkOut - more resources
Full Text Sources